(Q44169479)

30 November 2017

title

Survival benefits of angiotensin-converting enzyme inhibitors in older heart failure patients with perceived contraindications (English)

1 reference

30 November 2017

1 reference

1 reference

2

Catarina I Kiefe

1 reference

30 November 2017

Ali Ahmed

1

1 reference

30 November 2017

Richard M Allman

series ordinal

3

1 reference

30 November 2017

Richard V Sims

series ordinal

4

1 reference

30 November 2017

James F DeLong

series ordinal

5

1 reference

30 November 2017

language of work or name

English

0 references

publication date

1 October 2002

1 reference

Journal of the American Geriatrics Society

30 November 2017

published in

1 reference

30 November 2017

volume

50

1 reference

30 November 2017

issue

10

1 reference

30 November 2017

page(s)

1659-1666

1 reference

A congestive heart failure project with measured improvements in care

30 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1532-5415.2002.50457.X

Angiotensin-converting enzyme inhibitor-associated elevations in serum creatinine: is this a cause for concern?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1532-5415.2002.50457.X

Clinical effects of early angiotensin-converting enzyme inhibitor treatment for acute myocardial infarction are similar in the presence and absence of aspirin: systematic overview of individual data from 96,712 randomized patients. Angiotensin-conve

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1532-5415.2002.50457.X

Angiotensin-converting enzyme inhibitor use in older patients with heart failure and renal dysfunction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1532-5415.2002.50457.X

Can physicians always explain the results of clinical trials? A case study of amlodipine in heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1532-5415.2002.50457.X

Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1532-5415.2002.50457.X

Cardiology or primary care for heart failure in the community setting: process of care and clinical outcomes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1532-5415.2002.50457.X

Treatment of patients admitted to the hospital with congestive heart failure: specialty-related disparities in practice patterns and outcomes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1532-5415.2002.50457.X

Variations in family physicians' and cardiologists' care for patients with heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1532-5415.2002.50457.X

Comparing generalist and specialty care: discrepancies, deficiencies, and excesses

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1532-5415.2002.50457.X

The prognostic implications of renal insufficiency in asymptomatic and symptomatic patients with left ventricular systolic dysfunction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1532-5415.2002.50457.X

Mortality of the institutionalized old-old hospitalized with congestive heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1532-5415.2002.50457.X

Randomised controlled trial of enalapril and beta blockers in non-diabetic chronic renal failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1532-5415.2002.50457.X

A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1532-5415.2002.50457.X

Hyperkalemia in Outpatients Using Angiotensin-Converting Enzyme Inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1532-5415.2002.50457.X

Predictors of the development of hyperkalemia in patients using angiotensin-converting enzyme inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1532-5415.2002.50457.X

Why deny ACE inhibitors to patients with aortic stenosis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1532-5415.2002.50457.X

Reasons for underuse of angiotensin-converting enzyme inhibitors in patients with heart failure and left ventricular dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1532-5415.2002.50457.X

Angiotensin-converting-enzyme inhibitors in the management of cardiac failure: are we ignoring the evidence?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1532-5415.2002.50457.X

Are we inhibited? Renal insufficiency should not preclude the use of ACE inhibitors for patients with myocardial infarction and depressed left ventricular function

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1532-5415.2002.50457.X

Guidelines for the evaluation and management of heart failure. Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Evaluation and Management of Heart Failure)

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1532-5415.2002.50457.X

Randomised trial of losartan versus captopril in patients over 65 with heart failure (Evaluation of Losartan in the Elderly Study, ELITE)

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1532-5415.2002.50457.X

Why are angiotensin converting enzyme inhibitors underutilised in the treatment of heart failure by general practitioners?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1532-5415.2002.50457.X

Benefits-to-risks ratio in physician drug selection

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1532-5415.2002.50457.X

Orthostatic hypotension predicts mortality in elderly men: the Honolulu Heart Program

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1532-5415.2002.50457.X

Effect of ACE inhibitors in diabetic and nondiabetic chronic renal disease: a systematic overview of randomized placebo-controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1532-5415.2002.50457.X

Angiotensin-converting enzyme inhibition in nondiabetic progressive renal insufficiency: a controlled double-blind trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1532-5415.2002.50457.X

Quality of medical care delivered to Medicare beneficiaries: A profile at state and national levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1532-5415.2002.50457.X

10.1046/J.1532-5415.2002.50457.X

21 January 2018

Identifiers

DOI

1 reference

30 November 2017

1 reference